Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature

RATIONALE: Aromatase inhibitors (AIs) are a class of drugs widely used in the treatment of estrogen sensitive breast and ovarian cancer which convert testosterone to estradiol and androstenedione to estrogen. The AIs of third generation, including anastrazole, letrozole and exemestane, have actually...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenti, Sara, Giordano, Nicola, Cutolo, Maurizio, Giannini, Fabio, Fioravanti, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455664/
https://www.ncbi.nlm.nih.gov/pubmed/30921233
http://dx.doi.org/10.1097/MD.0000000000015052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455664/
https://www.ncbi.nlm.nih.gov/pubmed/30921233
http://dx.doi.org/10.1097/MD.0000000000015052

Ejemplares similares